Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?

J Am Acad Dermatol. 2013 Jan;68(1):173-6. doi: 10.1016/j.jaad.2012.06.037.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Basal Cell / prevention & control*
  • Carcinoma, Squamous Cell / prevention & control*
  • Celecoxib
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Diclofenac / therapeutic use
  • Humans
  • Keratosis, Actinic / drug therapy
  • Keratosis, Actinic / prevention & control*
  • Pyrazoles / therapeutic use
  • Skin Neoplasms / prevention & control*
  • Sulfonamides / therapeutic use

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Diclofenac
  • Celecoxib